Iambic Therapeutics tackles challenging design problems in drug discovery with its physics-based AI platform. Its automa...
Drug discovery is slow and difficult due to complex small-molecule design and target profile optimization challenges.
A physics-based AI platform with automated data pipelines and high-throughput chemistry/biology to design and generate small-molecule drug candidates.
Pharmaceutical and biotechnology R&D teams developing small-molecule therapeutics.





